Dual-Antigen-Targeting T Cell Immunotherapies in MM: Circumventing Tumor Heterogeneity and Preventing Antigen Escape

Dual-antigen targeting with T cell redirecting trispecific antibodies has demonstrated promising results in heavily pretreated multiple myeloma with several studies ongoing in earlier stages of the disease.